1. S.S. Chugh, R. Havmoeller, K. Narayanan, D. Singh, M. Rienstra, E.J. Benjamin, R.F. Gillum, Y.H. Kim, J.H. Mcanulty, Z.J.J.C. Zheng, Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study, 129(8) (2014) 837-847.
2. X. Luo, B. Yang, S.J.N.R.C. Nattel, MicroRNAs and atrial fibrillation: mechanisms and translational potential, 12(2) (2015) 80-90.
3. Q. Wang, W. Xi, L. Yin, J. Wang, H. Shen, Y. Gao, J. Min, Y. Zhang, Z.J.S.R. Wang, Human Epicardial Adipose Tissue cTGF Expression is an Independent Risk Factor for Atrial Fibrillation and Highly Associated with Atrial Fibrosis, 8(1) (2018) 3585-3585.
4. J. Liu, D. Hao, J. Zhang, Y.J.B. Zhu, B.R. Communications, Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a, 413(2) (2011) 342-347.
5. V. Kesherwani, S.S. Nandi, S.K. Sharawat, H.R. Shahshahan, P.K.J.M. Mishra, C. Biochemistry, Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes, 404(1) (2015) 241-250.